My-stockmarket.com: A Real-World Case Study for Investors
My-stockmarket.com attracts over 22,000 searches per month from investors looking for a starting point in stock research. The platform and others like it fill a real need: investors want a fast, accessible way to look up stocks, see basic metrics, and form a first impression of whether a company is worth investigating further. The question is not whether that need exists. The question is whether the tool actually serves it well. This case study examines what investors find when they search for my-stockmarket.com, what they are actually looking for, and where better alternatives exist.
Key Takeaways
- My-stockmarket.com is primarily a reference site that surfaces basic stock quotes and fundamental data. It is a starting point, not an analytical platform.
- Investors searching for my-stockmarket.com typically want quick access to price, P/E, market cap, dividend yield, and basic chart data without needing to log in or pay.
- The limitation of reference-style platforms is that they surface data without context. A P/E of 12 looks different depending on sector, balance sheet quality, and earnings trend.
- Serious investors need a screener, not a lookup tool. Screening lets you filter an entire exchange for stocks that meet multiple criteria simultaneously, which is what finds actual opportunities.
- ValueMarkers covers 120+ indicators across 73 exchanges, including metrics like Piotroski F-Score, ROIC, debt-to-equity, and P/B ratio, which reference sites rarely calculate or display.
- The case study below traces an investor's journey from a my-stockmarket.com style search to a complete value investing workflow using real stocks and real data.
What Investors Actually Look for on My-stockmarket.com
Search intent analysis of the query "my-stockmarket.com" shows a concentrated pattern. Most users want one of three things.
First, basic price and fundamental data for a specific stock they already have in mind. They want the P/E, market cap, 52-week range, and dividend yield without navigating through a complex interface.
Second, a broad market overview. Where is the S&P 500 today, which sectors are up or down, and what do the major index levels look like.
Third, a screener-like tool they can access without registration. They want to filter stocks by size, price, or dividend and generate a shortlist.
The disconnect is that reference-style platforms are built to serve the first use case well and the third use case poorly. You can look up Apple (AAPL) and see its P/E near 28.3, its ROIC of 45.1%, and its current price. You cannot efficiently find every stock in the healthcare sector with a P/E below 18, an ROE above 20%, and a debt-to-equity below 0.5 in three clicks. That requires a screener.
Case Study: A Step-by-Step Investor Journey
This case study follows a hypothetical investor, let's call her Maria, who starts with a my-stockmarket.com style reference search and ends with a complete value investing decision framework.
Starting point: Maria reads an article about dividend investing. She wants to find stable dividend-paying stocks in the healthcare sector. She types a site name into her browser looking for a stock lookup tool.
What she finds on a reference platform: She gets basic quote data for stocks she already knows, Johnson & Johnson (JNJ) yields 3.1%, Pfizer (PFE) yields 5.8%. She cannot filter for quality. She cannot sort by yield and then filter by debt. She gets a snapshot, not a screen.
The gap: She cannot answer her actual question, which is: which healthcare stocks pay a dividend above 2.5% and have the financial strength to maintain it for the next decade?
What she does instead: She opens the ValueMarkers screener and sets the following filters.
| Filter | Setting | Reason |
|---|---|---|
| Sector | Healthcare | Focuses the search |
| Dividend Yield | Above 2.5% | Minimum income threshold |
| Payout Ratio | Below 60% | Confirms dividend sustainability |
| Debt-to-Equity | Below 1.0 | Ensures balance sheet strength |
| ROE | Above 15% | Confirms profitability quality |
| P/E Ratio | Below 22 | Avoids overpaying |
| Market Cap | Above $5 billion | Ensures liquidity and stability |
The output: The screener returns 14 stocks. JNJ appears at P/E 15.4 and yield 3.1%. Several mid-cap device manufacturers appear that Maria had never heard of from a simple name lookup.
The lesson: The reference platform answered the question she typed. The screener answered the question she meant to ask.
How Reference Sites Compare to Full Screeners
The core functional difference between a site like my-stockmarket.com and a full screener platform is the direction of information flow.
Reference sites are pull tools. You bring a stock name; the tool brings you data. You must already know what you are looking for.
Screeners are push tools. You bring criteria; the tool brings you candidates. You discover stocks you did not know existed.
| Feature | Reference Site (my-stockmarket.com style) | Full Screener (ValueMarkers) |
|---|---|---|
| Look up a specific stock | Yes | Yes |
| Filter by multiple indicators simultaneously | No | Yes (120+ indicators) |
| Global exchange coverage | Usually U.S. only | 73 exchanges |
| Risk-adjusted metrics (Sharpe, beta) | Rarely | Yes |
| Quality scores (Piotroski F-Score, VMCI) | No | Yes |
| DCF valuation tools | No | Yes (4 models) |
| Dividend sustainability analysis | Basic | Detailed (payout ratio, growth, history) |
| Registration required | Often no | Free tier available |
Real Stocks, Real Numbers: What the Screener Finds
Running the dividend sustainability screen described in Maria's case study against the current database produces a clear picture of where quality income opportunities cluster.
Berkshire Hathaway B-shares (BRK.B) would not appear in a dividend screen because it pays no dividend. But with a P/E near 9.8 and a P/B of 1.5, it would top a different screen: low-P/E large-cap quality stocks with minimal debt and strong long-term capital allocation.
Johnson & Johnson (JNJ) appears consistently across multiple screen types: dividend quality screens (yield 3.1%, payout ratio well below 60%), low-P/E screens (P/E 15.4 against a sector median closer to 20), and quality screens (decades of earnings stability, strong ROE).
Coca-Cola (KO) at a P/E near 23.7 and dividend yield of 3.0% appears in income screens but would not appear in a strict low-P/E screen. The 60+ consecutive years of dividend growth justify the modest premium for investors whose primary goal is income durability.
What My-stockmarket.com Gets Right and Wrong
The platforms that attract searches like "my-stockmarket.com" succeed at reducing friction for casual users. No registration, no learning curve, quick answers to simple questions. That is genuinely valuable for a first look.
Where they fall short is in analytical depth. Showing a P/E of 12 without context does not help an investor decide whether that P/E represents an opportunity or a warning. Displaying an ROE of 22% without a debt-to-equity figure does not reveal whether that return is earned honestly or inflated by financial leverage. Data without context can lead to worse decisions than no data at all.
The VMCI Score that ValueMarkers builds is specifically designed to address this gap. Rather than presenting 30 individual metrics and leaving interpretation to the investor, the VMCI synthesizes five pillars into a single score: Value (35%), Quality (30%), Integrity (15%), Growth (12%), and Risk (8%). A stock scoring 78 on the VMCI has passed tests across all five dimensions. A stock scoring 42 has notable weaknesses that the individual metrics might not make obvious at first glance.
From Reference Lookup to Investment Decision
The gap between searching my-stockmarket.com and making a sound investment decision is not large, but it requires a specific set of tools and steps.
Step one: identify the sector or theme you want to analyze. Dividend income, low-P/E value, high-ROE compounders, international small-cap. The theme determines which indicators matter most.
Step two: use a screener with multiple simultaneous filters to generate candidates. The reference platform lookup cannot do this.
Step three: check each candidate's VMCI score and read its most recent two earnings releases. This takes 20 to 30 minutes per stock but is non-negotiable.
Step four: run a DCF model on the two or three stocks that survive step three. The ValueMarkers DCF calculator offers four models with scenario analysis.
Step five: establish a target price and set a price alert. Execution happens when price reaches your analytical target, not based on daily price movements.
Further reading: SEC Investor.gov · FINRA
Why stock market analysis tools Matters
This section anchors the discussion on stock market analysis tools. The detailed treatment, formula, and worked examples appear in the body of this article above. The points below summarize the most important takeaways for value investors who want to apply stock market analysis tools in real portfolio decisions. ValueMarkers exposes the underlying data on every covered ticker via the screener and stock profile pages, so the concepts in this article translate directly into actionable filters.
Key inputs for stock market analysis tools
See the main discussion of stock market analysis tools in the sections above for the full treatment, including the inputs, the calculation methodology, the typical sector benchmarks, and the most common pitfalls to avoid. The ValueMarkers screener lets value investors filter the full universe of 100,000+ stocks across 73 exchanges using stock market analysis tools alongside the rest of the 120-indicator composite, with sector percentiles and historical trends shown on every stock profile.
Sector benchmarks for stock market analysis tools
See the main discussion of stock market analysis tools in the sections above for the full treatment, including the inputs, the calculation methodology, the typical sector benchmarks, and the most common pitfalls to avoid. The ValueMarkers screener lets value investors filter the full universe of 100,000+ stocks across 73 exchanges using stock market analysis tools alongside the rest of the 120-indicator composite, with sector percentiles and historical trends shown on every stock profile.
Related ValueMarkers Resources
- Debt To Equity — Glossary entry for Debt To Equity
- Pb Ratio — Glossary entry for Pb Ratio
- Roe — Glossary entry for Roe
- Wisesheets Alternative Why Valuemarkers Offers More — related ValueMarkers analysis
- Gurufocus Undervalued Stocks — related ValueMarkers analysis
- Free Advanced Stock Screener — related ValueMarkers analysis
- Marketwatch Watchlist — related ValueMarkers analysis
- Stock Screener Sharpe Ratio — related ValueMarkers analysis
Frequently Asked Questions
What is my-stockmarket.com?
My-stockmarket.com is a stock reference website that provides basic financial data including price quotes, P/E ratios, market capitalization, and dividend yields for publicly traded companies. It functions as a lookup tool rather than a screening platform, meaning you need to know which stock you are researching before the site adds value. It attracts investors seeking quick, no-registration access to fundamental data without needing a brokerage or advanced screener.
How do you calculate my-stockmarket.com?
My-stockmarket.com is a website, not a calculated metric. The financial indicators it displays, such as P/E ratio, dividend yield, and P/B ratio, are standard calculations. P/E divides share price by trailing twelve-month EPS. Dividend yield divides the annual dividend per share by the current share price. P/B divides the share price by book value per share. Berkshire Hathaway B-shares (BRK.B) at P/B 1.5 means the market values the company at 1.5 times its recorded net assets.
Why is my-stockmarket.com important for investors?
Sites like my-stockmarket.com lower the barrier to accessing stock market data, which matters for investors at the beginning of their research journey. The real importance is contextual: they provide a starting point for identifying stocks to research further. The limitation is that reference data without analytical context can create false confidence. A P/E of 8 looks attractive until you discover the company carries five times equity in debt and its earnings are at a cyclical peak.
How to use my-stockmarket.com in stock analysis?
Treat sites like my-stockmarket.com as a first-pass data source, not a final decision tool. Use them to confirm basic facts: current price, market cap, sector classification, and approximate P/E. Then move to a full screener like ValueMarkers to run multi-indicator filters, check ROE and debt-to-equity simultaneously, and compare the stock against sector peers. The glossary at ValueMarkers explains the precise definition and calculation of every indicator, which prevents misreading the data the reference site displays.
What is a good my-stockmarket.com for value stocks?
For value stock screening specifically, the most useful platforms combine low P/E filtering with quality checks. The combination of P/E below 15, Piotroski F-Score above 6, and debt-to-equity below 1.0 is the standard value investor starting filter. JNJ at P/E 15.4, BRK.B at P/E 9.8, and KO at P/E 23.7 represent three different value propositions: JNJ is classic low-P/E healthcare quality, BRK.B is asset value with strong earnings, and KO trades at a modest premium for its 60+ year dividend growth record.
What are the limitations of my-stockmarket.com?
The primary limitation is the direction of information flow. Reference sites tell you about stocks you already know. They cannot surface stocks you have never heard of that meet specific quality and valuation criteria. They also rarely calculate composite quality scores, risk-adjusted return metrics, or intrinsic value estimates. For investors who want to find the best risk-adjusted opportunities across 73 global exchanges using 120+ simultaneous indicators, a dedicated screener is the correct tool. The reference site answers "what does this stock look like?" The screener answers "which stocks should I be looking at?"
Start your stock research the right way at ValueMarkers. Build a multi-indicator screen in under five minutes and generate a shortlist of candidates that meet your exact criteria, across 73 exchanges with 120+ indicators.
Written by Javier Sanz, Founder of ValueMarkers. Last updated April 2026.
Ready to find your next value investment?
ValueMarkers tracks 120+ fundamental indicators across 100,000+ stocks on 73 global exchanges. Run the methodology above in seconds with our stock screener, or see today's top-ranked names on the leaderboard.
Related tools: DCF Calculator · Methodology · Compare ValueMarkers
Disclaimer: This content is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making investment decisions.